Infliximab in UC
Budesonide as maintenance in CD
Natalizumab in CD
Lactobacillus rhamnosus strain GG in paediatric CD
Lack of efficacy of a reduced microparticle diet in a multi-centred trial of patients with active CD
Ornidazol in CD for postop recurrence
Mesalazine oral +/- topical in UC
Risk factors for inflammatory bowel disease in the general population (Nested case-controls. UK)